Aarti Industries Secures Methanol and Toluene Feedstock Supply Through Multiple Long-Term Contracts
MUMBAI, India, Dec. 19, 2025 /PRNewswire/ -- Aarti Industries Limited (AIL), a…
Servier’s Voranigo (vorasidenib) Receives Prix Galien Awards Across Multiple Regions
Voranigo® has been awarded the Prix Galien USA, the Prix Galien Poland and…
Lynozyfic (linvoseltamab) Monotherapy in Newly Diagnosed Multiple Myeloma (NDMM) Shows Impressive Responses, Supporting Rationale as a Potential Foundation in Frontline Treatment
All three dose groups (50 mg, 100 mg and 200 mg) showed…
Over HK$100 Million Donated by Multiple Web3 FinTech Companies to Support Fire Victims
HONG KONG, Nov. 29, 2025 /PRNewswire/ -- On November 26, a severe Level-5…
Johnson & Johnson Showcases Latest Advancements in Pulsed Field Ablation with Multiple Clinical and Real-world Studies at APHRS and JPHRS
Key oral presentations highlight new safety, efficacy and workflow improvements data to…
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
October 25, 2025 11:01 ET | Source: Cullinan Therapeutics, Inc. CLN-978 led…
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
October 24, 2025 11:39 ET | Source: PMV Pharmaceuticals, Inc. Data presented…
Monika Alcobev Limited Shines at the India Wine & Spirits Awards 2025, Secures Multiple Top Honours Across Categories
MUMBAI, India, Oct. 15, 2025/PRNewswire/ -- Monika Alcobev Limited, one of India's…
Blokees Debuts New “BLOKEES WHEELS” Category and Exhibits Multiple New Model Kits at Wonder Festival 2025
SHANGHAI, Oct. 2, 2025 /PRNewswire/ -- At Wonder Festival 2025, Assembly Character…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in…
